A Study of Dasatinib to See How Liver Impaired and Healthy Subjects Process and React to the Study Drug

Completed

Conditions studied: Liver Diseases

In brief

The primary purpose of this study is to evaluate how a person with liver impairment processes and reacts to the study drug. Information about any side effects that may occur will also be collected.

Key facts

Study ID

NCT00382668

Run by

Bristol-Myers Squibb

People needed

40

Starts

2006-10-01

Expected to finish

2007-08-01

Last updated by the study team

2011-04-14

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.

Where it is running

• University Of Miami — Miami, Florida, United States
• Comprehensive Phase One — Miramar, Florida, United States
• Orlando Clinical Research Center — Orlando, Florida, United States
• New Orleans Center For Clinical Research — Knoxville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.